Manulife (Manufacturers Life Insurance)
NERV icon

Manulife (Manufacturers Life Insurance)’s Minerva Neurosciences NERV Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,743
Closed -$70K – 3018
2020
Q3 		$70K Hold
2,743
– – ﹤0.01% 2865
2020
Q2 		$76K Buy
2,743
+234
+9% +$13.7K ﹤0.01% 2815
2020
Q1 		$121K Sell
2,509
-29
-1% -$1.75K ﹤0.01% 2519
2019
Q4 		$144K Sell
2,538
-173
-6% -$7.63K ﹤0.01% 2704
2019
Q3 		$177K Sell
2,711
-131
-5% -$7.42K ﹤0.01% 2649
2019
Q2 		$128K Buy
2,842
+1,302
+85% +$65.2K ﹤0.01% 2834
2019
Q1 		$97K Buy
1,540
+223
+17% +$13.4K ﹤0.01% 2578
2018
Q4 		$71K Sell
1,317
-230
-15% -$16.8K ﹤0.01% 2468
2018
Q3 		$155K Sell
1,547
-1,801
-54% -$135K ﹤0.01% 2828
2018
Q2 		$221K Buy
3,348
+464
+16% +$28.2K ﹤0.01% 3046
2018
Q1 		$144K Sell
2,884
-23
-0.8% -$1.1K ﹤0.01% 3260
2017
Q4 		$141K Sell
2,907
-224
-7% -$11.1K ﹤0.01% 3265
2017
Q3 		$191K Buy
3,131
+336
+12% +$19.3K ﹤0.01% 3021
2017
Q2 		$198K Buy
2,795
+781
+39% +$50.5K ﹤0.01% 3013
2017
Q1 		$130K Buy
2,014
+239
+13% +$18.6K ﹤0.01% 3071
2016
Q4 		$166K Buy
1,775
+57
+3% +$5.82K ﹤0.01% 2933
2016
Q3 		$194K Buy
1,718
+151
+10% +$14.7K ﹤0.01% 2794
2016
Q2 		$128K Buy
1,567
+1,422
+981% +$90.4K ﹤0.01% 3072
2016
Q1 		$7K Buy
+145
New +$6.19K ﹤0.01% 3712

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NERV Position: Q4 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of Minerva Neurosciences (NERV) in Q4 2020, closing a stake of 2,743 shares — an estimated $70K sold.

Manulife (Manufacturers Life Insurance) first reported a position in NERV in Q1 2016 and held it in 19 quarters. The position peaked at $221K in Q2 2018. 76 funds tracked by Wall St. Rank hold NERV as of Q4 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining Minerva Neurosciences position as of Q4 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 2,743 Minerva Neurosciences shares in Q4 2020, an estimated $70K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Minerva Neurosciences in Q1 2016 and held it in 19 quarters.
  • Manulife (Manufacturers Life Insurance)'s Minerva Neurosciences position peaked at $221K in Q2 2018.
  • 76 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2020, filed 12 Feb 2021.